同比增长50%！九州通近三万家加盟药店去年销售突破70亿元

Core Insights - The Hubei Provincial Conference on the Development of the Private Economy highlighted the growth of Jiuzhoutong Pharmaceutical Group, which has nearly 30,000 franchise pharmacies and expects sales to exceed 7 billion yuan in 2024, representing a 50% year-on-year increase [1][2] Company Overview - Jiuzhoutong was listed on the Shanghai Stock Exchange in 2010 and currently has 682 holding companies and over 30,000 employees [1] - For the first three quarters of 2024, the company achieved a revenue of 113.4 billion yuan, ranking 176th among China's top 500 companies and 55th among private enterprises [1] Strategic Initiatives - The company is advancing its "Three New and Two Transformations" strategy, focusing on new products, new retail, new medical services, digitalization, and real estate securitization [2] - In the new product segment, Jiuzhoutong has established four R&D institutions and collaborates with several research institutes, with an annual R&D expenditure of 200-300 million yuan [2] - The new retail initiative has seen nearly 30,000 franchise pharmacies, with projected sales of over 7 billion yuan in 2024, marking a 50% increase [2] - In the new medical sector, the company has developed a "digital + supply chain" system, with 1,366 franchise clinics and plans to exceed 10,000 clinics in the next five years [2] - The digitalization effort includes a dedicated leadership team and over 1,400 IT engineers, completing more than 100 digital projects [2] - Jiuzhoutong successfully issued the first public REITs for pharmaceutical warehousing and logistics assets in the industry, raising 1.158 billion yuan [2] Corporate Governance - In 2020, Jiuzhoutong transitioned from founder-led management to a professional management team, which is currently functioning well [2] - The company aims to optimize its institutional mechanisms to establish a modern corporate governance system and contribute to the construction of Hubei's economic framework [2]